California Academy of Family Physicians (CAFP)
MAY 14, 2025
Proposed Changes to Medi-Cal Coverage for Undocumented Individuals Enrollment Freeze for Full-Scope (State-Only) Medi-Cal Expansion to Undocumented Adults – Freezes new enrollment for undocumented adults aged 19 and older, effective January 1, 2026. The policy would be effective January 1, 2026.
FDA Law Blog
SEPTEMBER 16, 2024
Regarding CDER’s ETP, the current ETP guidance document, originally published in 2017, will be updated by the end of 2026, and will include details on communicating the type of products and stages of development for which a requestor can approach the ETP. Finally, the ETT will establish program goals and performance measures for the ETP.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
SEPTEMBER 20, 2021
Notable Dates and Timelines – Program opens, beginning of FY 2023; Expediting reviews fully implemented, by FY 2024; Webpage with detailed criteria for acceptance and participation, October 1, 2022; Interim assessment, end of FY 2025; Public workshop, end of Q2 FY 2026. Notable Dates and Timelines – Applications open, Q4 of FY 2023.
Alabama Academy of Family Physicians
FEBRUARY 19, 2025
It then establishes a new Rural Physician Income Tax Credit program, effective January 1, 2026, that provides a $10,000 annual tax credit to qualifying rural physicians for up to four tax years. These funds could be utilized for various purposes, including direct care, operational expenses, and facility maintenance or upgrades.
FDA Law Blog
AUGUST 14, 2022
The number will begin in 2026 with 10 drug covered under Medicare Part D and will increase annually to 20 Part B and 20 Part D drugs by 2029 and thereafter, with the selected drugs accumulating from year to year. Manufacturers receive no benefits in exchange for the inflation rebates.
FDA Law Blog
SEPTEMBER 14, 2021
The original January 29, 2021 effective date of that rule has been postponed several times pursuant to court orders and is likely to be again postponed until January 1, 2026 pursuant to a provision of the Senate infrastructure bill that is expected to pass the House and be signed by the President (see our post here ).
FDA Law Blog
SEPTEMBER 13, 2021
A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate. Last Thursday, the U.S.
Expert insights. Personalized for you.
204 
Let's personalize your content